Signal-regulatory protein-␣ (SIRP␣) is a transmembrane protein that contains tyrosine phosphorylation sites in its cytoplasmic region; two tyrosine phosphatases, SHP-1 and SHP-2, bind to these sites in a phosphorylationdependent manner and transduce multiple intracellular signals. Recently, SIRP␣ was identified as one of the major tyrosine-phosphorylated proteins in the glomeruli and found to be expressed in podocytes. In the present study, we examined the role of SIRP␣ expression in podocytes using knockin mice (C57BL/6 background) expressing mutant SIRP␣ that lacks a cytoplasmic region (SIRP␣-mutant mice). Light microscopic examination revealed no apparent morphological abnormalities in the kidneys of the SIRP␣-mutant mice. On the other hand, electron microscopic examination revealed abnormal podocytes with irregular major processes and wider and flattened foot processes in the SIRP␣-mutant mice compared with their wild-type counterparts. Significantly impaired renal functions and slight albuminuria were demonstrated in the SIRP␣-mutant mice. In addition, adriamycin injection induced massive albuminuria together with focal glomerulosclerosis in the SIRP␣-mutant mice, while their wild-type counterparts were resistant to adriamycin-induced nephropathy. These data demonstrate that SIRP␣ is involved in the regulation of podocyte structure and function as a filtration barrier under both physiological and pathological conditions. SIRP␣; podocytes; proteinuria; adriamycin nephropathy PODOCYTES ARE TERMINALLY DIFFERENTIATED cells that play a crucial role in regulating the glomerular filtration barrier. They possess a body extending major processes that further branch into foot processes separated by a slit diaphragm and cover the outside of the glomerular capillary (28). The function of podocytes is largely based on their complex cellular architecture, particularly on the normal foot process structure with highly ordered parallel contractile actin filament bundles (17). A number of genes encoding proteins that are localized within the podocyte foot processes, especially at the slit diaphragm, have been identified over the past several years, and mutations of some of these genes are known to be associated with hereditary nephrotic syndrome and renal insufficiency (23).
SIRP␣; podocytes; proteinuria; adriamycin nephropathy PODOCYTES ARE TERMINALLY DIFFERENTIATED cells that play a crucial role in regulating the glomerular filtration barrier. They possess a body extending major processes that further branch into foot processes separated by a slit diaphragm and cover the outside of the glomerular capillary (28) . The function of podocytes is largely based on their complex cellular architecture, particularly on the normal foot process structure with highly ordered parallel contractile actin filament bundles (17) . A number of genes encoding proteins that are localized within the podocyte foot processes, especially at the slit diaphragm, have been identified over the past several years, and mutations of some of these genes are known to be associated with hereditary nephrotic syndrome and renal insufficiency (23) .
Recent studies have shown that tyrosine phosphorylation of proteins expressed in the slit diaphragm, such as nephrin and Neph1, is critically involved in the maintenance of the glomerular filtration barrier (3, 10, 29) . Phosphorylation of tyrosine sites in the cytoplasmic domains of these slit diaphragm proteins triggers recruitment of adaptor proteins that regulate the podocyte actin cytoskeleton in a tyrosine phosphorylationdependent manner (3, 10) .
Signal-regulatory protein-␣ (SIRP␣), also known as SHPS-1, p84, and BIT, is a transmembrane protein that contains three immunoglobulin-like domains in its extracellular domain and putative tyrosine phosphorylation sites, called immunoreceptor tyrosine-based inhibitory motifs (ITIMs), in its cytoplasmic domain (16) . The extracellular immunoglobulin-like domains share a particularly close structural similarity to T cell and B cell receptor chains (5) . Various growth factors, cytokines, and events, such as integrin-mediated cell adhesion to extracellular matrix proteins and binding to CD47, a widely expressed transmembrane protein and ligand for SIRP␣, induce tyrosine phosphorylation in the cytoplasmic domain of SIRP␣ (16, 22) . The tyrosine-phosphorylated sites of SIRP␣ subsequently bind and activate the Src homology region 2 (SH2) domain containing protein tyrosine phosphatases, SHP-1 or SHP-2. Therefore, SIRP␣ functions as a docking protein to recruit and activate SHP-1 or SHP-2 at the cell membrane in response to extracellular stimuli and transduce outside signals into cells (16) .
Previous studies have revealed that SIPR␣ is predominantly expressed in neurons, dendritic cells, and macrophages (16) . Recently, investigation of tyrosine-phosphorylated proteins in the normal rat kidney by two-dimensional gel electrophoresis and immunoprecipitation with anti-phosphotyrosine antibodies revealed SIRP␣ as one of the major tyrosine-phosphorylated proteins (33) . Immunofluorescence microscopic and immunoelectron microscopic examinations have shown that SIRP␣ is predominantly localized in the foot processes of the podocytes (33) . In addition, the direct interaction of SIRP␣ and nephrin was demonstrated in vivo and in vitro (11) . In the current study, we further examined the role of SIRP␣ in maintaining the structure and function of podocytes using knockin mice expressing mutant SIRP␣ that lacks the cytoplasmic domain containing four putative tyrosine-phosphorylated sites (SIRP␣-mutant mice) ( Fig. 1) (7) . The mutant mice provide us with a good model with which to study the role of the SIPR␣ signal pathway, because the binding of SHP-1 or SHP-2 to the cytoplasmic region is an obligatory step to transmit SIRP␣-mediated signals into cells.
MATERIALS AND METHODS
Mice and induction of adriamycin nephropathy. The generation of mice expressing a mutant form of SIRP␣ that lacks most of the cytoplasmic domain of the protein have been described elsewhere (7) . The mutant mice were backcrossed onto C57BL/6 background mice for five generations (8, 19, 21) . Eight-to nine-week-old male mice were used for the experiments. Blood pressure was measured by tail-cuff plethysmography in conscious mice using the UR-1000 device (Ueda Avancer, Tokyo, Japan). Mean blood pressure was calculated as diastolic blood pressure ϩ 1/3 ϫ (systolic blood pressure Ϫ diastolic blood pressure). For induction of adriamycin nephropathy, the SIRP␣-mutant mice and their wild-type counterparts were administered a single injection of adriamycin at 10 mg/kg (doxorubicin hydrochloride; Sigma-Aldrich, St. Louis, MO) via the tail vein 1 wk after heminephrectomy. The mice were euthanized 70 days after adriamycin injection. The mice were bred and maintained at the Institute of Experimental Animal Research of Gunma University under specific pathogen-free conditions and were handled using protocols approved by the Animal Care Committee of Gunma University.
Primary antibodies. The primary antibodies used in this study were as follows: rabbit polyclonal anti-SIRP␣ antibody that recognizes the cytoplasmic region of SIRP␣ (ABR Affinity BioReagents, Golden, CO); guinea pig polyclonal anti-nephrin antibody (PROGEN Biotechnik, Heidelberg, Germany); rabbit monoclonal anti-phosphorylated nephrin (pY1176/1193; Epitomics; Burlingame, CA); rabbit monoclonal anti-WT1 antibody (Epitomics); mouse monoclonal anti-synaptopodin antibody (PROGEN); mouse monoclonal anti-podocalyxin (R&D Systems, Minneapolis, MN); rabbit polyclonal anti-vimentin antibody (Cell Signaling Technology, Beverly, MA); mouse monoclonal anti-␤ actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA); rabbit polyclonal anti-SHP-1 antibody (Santa Cruz Biotechnology); mouse monoclonal anti-SHP-2 antibody (Santa Cruz Biotechnology); and mouse monoclonal anti-phosphotyrosine antibody (4G10; Millipore, Billerica, MA). Hybridoma cells producing the rat p84 monoclonal antibody, which recognizes extracellular region of SIRP␣, were provided by Dr. Carl F. Lagenaur (University of Pittsburgh, Pittsburgh, PA).
Histochemistry and immunohistochemistry. Kidneys were fixed in Carnoy's solution or 4% paraformaldehyde and embedded in paraffin. Four-micrometer sections were stained with periodic acid-Schiff (PAS). For immunohistochemical analysis, the 4-m-thick sections were deparaffinized, treated with 1% metaperiodic acid in phosphatebuffered saline (PBS) for 45 s at room temperature to block endogenous peroxidase, and microwaved at 500 W for 15 min in 10 mmol/l citric acid to retrieve the antigens. The sections were then incubated overnight at 4°C with the primary antibodies. After washing with PBS, the sections were incubated with the biotinylated secondary antibody (Vector Laboratories). The VECTASTAIN ABC reagent (Vector Laboratories) was used for signal amplification, and detection was performed using diaminobenzidine (Nichirei). The slides were counterstained with methyl green. The number of podocytes in a glomerulus was calculated based on the WT-1 staining. The average number was estimated by counting 25 glomeruli in each mouse.
Immunofluorescent staining. For immunofluorescence analysis of glomeruli, kidneys were quick-frozen in liquid nitrogen and stored at Ϫ80°C. Four-micrometer sections were fixed with cold methanol/ acetone (1:1) for 10 min at Ϫ20°C. The slides were incubated with the primary antibodies, followed by incubation with Alexa Fluor 488 (green)-conjugated anti-rabbit IgG or anti-mouse IgG (Molecular Probes, Eugene, OR), Alexa Fluor 568 (red)-conjugated anti-mouse IgG (Molecular Probes), or FITC-conjugated anti-guinea pig IgG antibody (Molecular Probes) at room temperature for 2 h.
Transmission electron microscopy. Kidneys were cut into small pieces, fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, and postfixed in 1% osmium tetroxide. The specimens were then dehydrated using a graded ethanol series, immersed in propylene oxide, and embedded in epoxy resin. Ultrathin sections were cut with a Leica ultramicrotome and stained with uranyl acetate and lead citrate. The sections were examined under a JEM-100CXII transmission electron microscope (JEOL, Tokyo, Japan).
Scanning electron microscopy. For scanning electron microscopy, specimens were fixed in a mixture of 2.5% glutaraldehyde and 2% formaldehyde in cacodylate buffer. After fixation, the glomeruli were exposed to a DMSO freeze-cracking method (26) and then conductively stained using 2% tannic acid and 1% osmium tetroxide. After dehydration through a graded series of ethanol, the specimens were transferred to t-butyl alcohol and dried in a freeze-drying device (VFD-20; Vacuum Device, Ibaraki, Japan). The dried specimens were sputter-coated with platinum-palladium using an ion coater (IB-2 ion-coater; Eiko Engineering, Ibaraki, Japan) and observed by scanning electron microscopy (Hitachi S-800; Hitachi, Tokyo, Japan) at 10 kV.
Immunoelectron microscopy. For immunoelectron microscopy, cryostat sections were washed three times in PBS for 15 min each and incubated with 3% bovine serum albumin (BSA)-PBS containing 0.02% saponin for 20 min. They were then incubated with the rabbit anti-SIRP␣ antibody (1:50 dilution in 1% BSA-PBS containing 0.005% saponin) overnight at 4°C and washed with PBS containing 0.005% saponin four times for 5 min each. Next, the sections were incubated with gold particles conjugated to Fab= fragments of antirabbit IgG (Nanogold; Nanoprobes) diluted 1:100 with 1% BSA-PBS containing 0.005% saponin for 2 h, and washed with PBS containing 0.005% saponin for 20 min, with six changes. Sections were then fixed in 1% glutaraldehyde for 10 min, washed thoroughly with water, and incubated with silver enhancement solution comprising 1 mg/ml of silver acetate, 14 mg/ml of trisodium citrate dihydrate, 15 mg/ml of citric acid monohydrate, and 2.5 mg/ml of hydroquinone for 8 min. After a quick rinse twice with water, they were immersed in 0.05% sodium acetate for 1 min and washed with water six times for 2 min each. The sections were then treated with 0.05% gold chloride trihydrate for 2 min at room temperature, washed with water six times, and fixed in 1% osmium tetroxide in 0.1 M sodium phosphate buffer, pH 7.4, for 20 min. The specimens were washed with water three times, dehydrated with ethanol, and embedded in epoxy resin. Ultrathin sections were cut, stained with uranyl acetate, and examined under a JEM-100CXII electron microscope (JEOL).
Measurement of glomerular number and scoring of the severity of glomerulosclerosis. For measurement of glomerular number, light microscopic images of renal sections stained by PAS were captured using Viewfinder (ver. 3.0.1; Pixera) and analyzed using Adobe Photoshop CS4 Extended (Adobe Systems). The area of renal cortex was quantified in pixel units. More than 100 sequential glomeruli were counted, and glomerular number per 1 mm 2 was obtained. In cases of adriamycin nephropathy, the glomerular damage was quantified by grading the severity of the sclerosis and hyalinosis in the glomeruli on PAS-stained sections, on a scale of 0 to 4, as described previously (6) . The percent area of sclerosis and hyalinosis in each glomerulus was scored as follows: 0, no lesion; 1, 25%; 2, 25-50%; 3, 50 -75%; 4, 75%. More than 50 sequential glomeruli from each mouse were evaluated, and the average score of sclerosis and hyalinosis per glomerulus was calculated.
Measurement of podocyte foot processes. For quantitative analysis of changes in podocyte foot processes on transmission electron micrographs, images were processed using Scion Image software (Scion, Frederick, MD). Five capillary loops in each of five randomly selected glomeruli per specimen were selected. In the newborn kidney, the area of well-formed foot process was also randomly selected. The number of foot processes was counted manually and expressed as the number of foot processes per 10-m length of glomerular basement membrane (GBM). The average number of foot processes in 25 capillary loops per specimen was estimated.
Urine and serum analysis. Individual mice were placed in metabolic cages for 24-h urine collections under normal conditions and at 2-10 wk after the injection of adriamycin. Urinary albumin concentration was determined using a competitive ELISA kit (Albuwell M; Exocell, Philadelphia, PA). Serum and urinary creatinine concentration were assessed in a Hitachi 7180 autoanalyzer (Hitachi) and JCA-BM8000 autoanalyzer (JEOL), respectively. The creatinine clearance was calculated using the standard equation: creatinine clearance ϭ (urine creatinine/serum creatinine) ϫ urine volume. Urine samples were also analyzed by 7.5% SDS-PAGE, which were stained with Simply Blue Safe Stain (Invitrogen).
Western blot analysis. Protein was extracted from homogenized whole kidneys, spleens, or isolated glomeruli using TG buffer (1% Triton, 10% glycerol, 20 mmol/L HEPES, 100 mmol/L NaCl). The protein concentration was determined by the BCA protein assay (Pierce, Rockford, IL) in accordance with the manufacturer's directions. Protein extract was separated on a 7.5% SDS gel and transferred to a polyvinyl difluoride membrane (Immobilon-P, Millipore). After blocking with 5% nonfat dry milk (Cell Signaling) to reduce nonspecific antibody binding, the membrane was incubated with primary antibodies overnight at 4°C, washed with Tris-buffered saline (20 mM Tris·HCl, 150 mM NaCl, and 0.1% Tween 20), and incubated with an alkaline phosphatase-conjugated anti-rabbit IgG, anti-mouse IgG antibody (Promega), or anti-guinea pig IgG antibody (Santa Cruz Biotechnology) at room temperature for 1 h. After further washing, detection of the bound antibody was performed using the chromogen 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (SigmaAldrich). Coimmunoprecipitation analysis. Protein extracts from isolated glomeruli were incubated for 4 h at 4°C with anti-SIRP␣ antibody (P84)-bound protein G-Sepharose beads (GE Healthcare, Waukesha, WI). The beads were then washed twice with 1 ml of lysis buffer (20 mM Tris·HCl, pH 7.6, 140 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM sodium fluoride, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 1 mM sodium vanadate), resuspended in SDS sample buffer, and subjected to SDS-PAGE followed by immunoblot analysis with primary antibodies. Immune complexes were detected with an ECL detection kit (Amersham Pharmacia Biotech, Piscataway, NJ).
Glomerular isolation. Glomerular isolation was performed using magnetic beads, according to a previously described method (25) .
Briefly, mice were perfused through the heart with magnetic 4.5-mdiameter Tosyl-activated Dynabeads (Invitrogen Dynal, Oslo, Norway) prepared in Hank's balanced salt solution (HBSS). Kidneys were minced into 1-mm 3 pieces with a razor blade, digested with collagenase and DNAse (Roche Applied Science, Indianapolis, IN) for 30 min, and filtered through a 100-m cell strainer. The glomeruli were collected with a magnet, washed with HBSS four times, and subjected to Western blot analysis.
Statistical analysis. All data were expressed as means Ϯ SE. Differences between experimental groups were evaluated by a twotailed t-test or repeated measures ANOVA using SPSS Statistics ver. 19.0 (SPSS Japan, Tokyo, Japan). P Ͻ 0.05 was regarded as denoting statistical significance.
RESULTS
SIRP␣ is expressed in mouse podocytes. Until now, the expression of SIRP␣ in podocytes has been reported in rats and humans but not in mice (11, 14, 33) . Therefore, we are the first to determine the expression of SIPR␣ in mouse podocytes. Wild-type mouse kidneys were stained with anti-SIRP␣ antibody directed against the C terminus (cytoplasmic region). SIPR␣-mutant mice served as the negative controls. Immunohistochemical staining revealed prominent expression of SIRP␣ in the glomeruli of wild-type mice ( Fig. 2A) . Double immunofluorescence staining revealed that the SIRP␣ expression was colocalized with the podocyte-specific marker synaptopodin, demonstrating that mouse podocytes expressed SIRP␣ (Fig. 2B) . Immunoelectron microscopy revealed that the SIRP␣ was mainly localized at the surface of the podocytes, including cell bodies, major processes, and foot processes (Fig.  2C) . Western blot analysis also confirmed the pronounced SIRP␣ expression in glomerular extracts (Fig. 2D) .
SIRP␣-mutant mice showed increased urinary albumin excretion and decreased renal function. We next measured urinary albumin excretion. Twenty-four-hour urine samples were collected using a metabolic cage. SIRP␣-mutant mice at the age of 8 wk showed faint, but significant, albuminuria (0.084 Ϯ 0.008 vs. 0.039 Ϯ 0.008 mg/day, SIRP␣-mutant vs. wild-type, P Ͻ 0.01) (Fig. 3A) . SDS-PAGE of spot urine samples stained with Simply Blue Safe Stain showed increased albumin excretion in the mutant mice compared with the wild-type mice (Fig.  3B) . As shown in Table 1 , the mutant mice showed significantly higher systolic blood pressure levels compared with their wild-type counterparts, although diastolic and mean blood pressure were not different between both groups of mice. In addition, the mutant mice showed significantly impaired renal function as determined by the blood urea nitrogen and creatinine clearance. SIRP␣-mutant mice showed normal morphological structure on light microscopy. We then examined the morphological changes in the kidneys of the SIRP␣-mutant mice. The kidney weights were similar between the wild-type and SIPR␣-mutant mice at the age of 8 wk (Table 1) . On light microscopic examination, there were no apparent morphological differences in the kidney in either type of mice, including in terms of the number of glomeruli (Fig. 4A, Table 1 ). Immunofluorescent study also revealed no significant alterations of the podocytespecific markers nephrin, podocalyxin, or synaptopodin (Fig.  4B) . The expression of vimentin, which is a major intermediate filament of the podocyte, was also identical (Fig. 4B) . The numbers of podocytes as determined by WT-1 staining were also similar (Fig. 4B, Table 1 ). Of note, the extracellular domain of SIRP␣ was expressed in the glomeruli of SIRP␣-mutant mice, which was detected by an antibody against extracellular domain of SIRP␣ (Fig. 4B) .
SIRP␣ was tyrosine phosphorylated and associated with SHP-2 in glomerular extracts of wild-type mice.
To determine the tyrosine-phosphorylation status of SIRP␣, we performed a coimmunoprecipitation study in isolated glomerular extracts from wild-type and SIRP␣-mutant mice, using an anti-SIRP␣ antibody (p84), which recognizes the extracellular region of SIRP␣. As shown in Fig. 5A , tyrosine-phosphorylation of SIRP␣ was observed in the wild-type mice but not in the mutant mice. In addition, the binding of SHP-2 to SIRP␣ was observed in the wild-type mice. However, the expression amounts of total nephrin and its tyrosine-phosphorylated forms (pY1176/1193) in the glomeruli as determined by Western blot analysis were similar between the wild-type and mutant mice (Fig. 5B) .
SIRP␣-mutant mice exhibited morphological abnormalities in podocytes on electron microscopy. We then conducted transmission and scanning electron microscopy to examine the fine structure of the podocytes. On the transmission electron microscopy, well-formed mature foot processes as well as flattened immature foot processes were both observed in glomeruli from wild-type and SIRP␣-mutant mice. The proportion of mature and immature foot processes appeared not different between wild-type and mutant mice (Fig. 6A) . In contrast, SIRP␣-mutant mice at the age of 8 wk exhibited blunting and widening of the foot processes compared with the wild-type mice of the same age, which had mature foot processes covering almost the entire GBM (Fig. 6B) . To numerically compare foot process morphology, the average number of foot processes per 10-m length of GBM was determined by images of the transmission electron microscopy. In the newborn kidney, the average number did not differ significantly between wild-type and mutant mice either when mature (wellformed) and immature (flattened) foot processes were counted together (22.5 Ϯ 1.3 vs. 22.5 Ϯ 1.0, wild-type vs. SIRP␣-mutant, not significant) or when only mature foot processes were counted (31.6 Ϯ 1.0 vs. 30.3 Ϯ 1.1, wild-type vs. mutant, not significant). However, at 8 wk, the average number of foot processes was significantly decreased in the SIRP␣-mutant mice compared with their wild-type counterparts (33.4 Ϯ 0.8 vs. 22.9 Ϯ 1.4, wild-type vs. SIRP␣-mutant, P Ͻ 0.01, Fig.  6C ). On scanning electron microscopy, the SIRP␣-mutant mice at 8 wk showed irregular major processes and wider foot processes compared with their wild-type counterparts (Fig.  6D) .
Adriamycin treatment induced massive albuminuria in the SIRP␣-mutant mice. Adriamycin nephropathy is a well-established rodent model, which is analogous to human focal segmental glomerulosclerosis (15) . C57BL/6 mice, which is the background to which the SIRP␣-mutant and wild-type mice in the current study belonged, are resistant to adriamycin, whereas BALB/c mice are susceptible to it (34) . However, genetically engineered mice, such as podocyte-specific Myh9-deleted mice or podocyte-specific autophagy-related 5-deleted mice, were shown to exhibit increased susceptibility to adriamycin injury even under the C57BL/6 background (4, 9). To determine the role of SIRP␣ in the responses to podocyte injury, adriamycin was administered to uninephrectomized SIRP␣-mutant mice and wild-type mice. Adriamycin induced significantly massive albuminuria from day 28 after adriamycin injection in the SIRP␣-mutant mice, but not in the wildtype mice (Fig. 7A) . SIRP␣-mutant mice showed focal glomerulosclerosis on light microscopy and effacement of the foot processes on electron microscopy at 70 days after adriamycin injection (Fig. 7, B and C) . The glomerular changes, namely sclerosis and hyalinosis, were graded in severity. SIRP␣-mutant mice exhibited significantly higher sclerosis and hyalinosis scores compared with the wild-type mice (Fig. 7D) .
DISCUSSION
Multiple membrane proteins are known to be present in the slit diaphragm, and they are connected to the actin cytoskeleton through a variety of adaptor and effector proteins (1, 17) . These proteins may function as key sensors and regulators of permanent changes in the shape and length of the foot processes (1, 17) . Recent studies have revealed that phosphorylation of the slit diaphragm proteins is important in the regulation of their functions (3, 10, 29) . By using anti-phosphotyrosine antibodies, SIRP␣ was identified as one of major tyrosine-phosphorylated proteins in the rat kidney (33). The first major finding of the present study is that SIRP␣-mutant mice, carrying SIRP␣ lacking the cytoplasmic domain which contains putative tyrosine phosphorylation sites, showed abnormal podocytes with irregular major processes and blunting and widening of the foot processes. In addition, the mutant mice showed deteriorated renal function even under normal conditions. Because the main function of SIRP␣ is to recruit and activate, upon phosphorylation of the tyrosine phosphorylation sites in its cytoplasmic domain, the non-receptor protein tyrosine phosphatases, SHP-1 or SHP-2, at the cell membrane (16), mutant SIRP␣ does not form a complex with SHP-1 or SHP-2 and fails to function as A: coimmunoprecipitation study. Isolated glomerular extracts from WT mice and Mu mice were incubated with anti-SIRP␣ antibody (p84)-bound-protein G beads. Immunoblot analysis showed both WT and Mu SIRP␣ was captured with p84 antibody, which recognizes the extracellular region of SIRP␣, although the molecular weight of SIRP␣ of Mu mice was smaller (indicated as *) than that of WT mice due to the deletion of the cytoplasmic region. The tyrosine-phosphorylation of SIRP␣ of WT mice was detected with antiphosphotyrosine antibody (4G10), whereas no signal was detected in the SIRP␣ of Mu mice. The association of tyrosine phosphatase SHP-2 with SIRP␣ was observed in the WT mice. Note that a faint band in the lane of Mu mice is due to nonspecific binding of SHP-2 to the beads, because Mu mice do not have the cytoplasmic region where SHP-2 binds. B: Western blot analysis for total nephrin and phosphorylated nephrin (pY1176/1193). Isolated glomerular extracts from WT and Mu mice showed no apparent differences in the expression amounts of total and phosphorylated nephrin.
an activator of SHP-1 and SHP-2 (7, 16) . SHP-2 is ubiquitously distributed in most cells, whereas SHP-1 is predominantly expressed in the hematopoietic cells (2) . With a coimmunoprecipitation study, we showed that SIRP␣ was tyrosine phosphorylated and associated with SHP-2 in the wild-type mice under normal conditions. Therefore, defective activation of SHP-2 may be responsible for the abnormal shapes of the podocytes in the SIRP␣-mutant mice. Although not only SHP-2 but also SHP-1 was found to be expressed in podocytes of normal mouse kidney by immunohistochemical staining, the binding of SHP-1 to SIRP␣ was not detected by coimmunoprecipitation analysis (data not shown). Interestingly, mice deficient in glomerular epithelial protein 1 (GLEPP1), a receptor protein tyrosine phosphatase, were reported to exhibit similar morphological abnormalities, namely, less distinct major processes and more blunted and wider foot processes compared with their wild-type counterparts (31) . In addition, GLEPP1-deficient mice also showed a reduced glomerular filtration rate, similar to the SIRP␣-mutant mice, possibly due to the reduced filtration surface area resulting from the structural changes in the podocytes described above (31) . Thus aberrant regulation of tyrosine phosphatases may lead to altered podocyte structure and function. However, there are differences between the GLEPP1-deficient mice and SIPR␣-mutant mice. GLEPP1-deficient mice did not show any detectable increase in urinary albumin excretion, whereas the SIPR␣-mutant mice showed a faint, but significant, increase. In addition, GLEPP-1-deficient mice revealed an increased amount of vimentin expression in podocytes compared with the wild-type mice, whereas the SIRP␣-mutant mice did not show apparent differences. To date, the critical downstream targets responsible for the morphological changes of the podocytes in In the newborn kidney, there was no significant (ns) difference between WT mice and Mu mice both in the total area around the GBM (Total) and in the selected area where well-formed foot processes were observed (Well-formed). However, the Mu mice at 8 wk showed significantly fewer foot processes compared with the WT mice at the same age. D: scanning electron microscopy demonstrated more irregular major processes and wider foot processes in the Mu mice compared with the WT mice. Bars ϭ 10 m (top) and bars ϭ 1 m (bottom).
GLEPP1-deficient or SIRP␣-mutant mice have not yet been identified. The molecular targets of the GLEPP1 and SIRP␣ signaling pathways for maintaining normal podocyte structure and function still remain to be elucidated. In contrast to the morphological abnormalities of the podocyte foot processes, the abnormality of urinary albumin excretion was only modest in the SIRP␣-mutant mice under normal conditions. This could be due to the preserved slit diaphragm proteins, such as nephrin, in the mutant mice. However, the second major finding of the current study is that the loss of the SIRP␣ signaling pathway resulted in further worsening of podocyte injury in adriamycin nephropathy, manifested by the markedly more severe albuminuria than that in the wild-type mice, associated with effacement of the foot processes and glomerulosclerosis. Because SIRP␣-mutant mice showed higher systolic blood pressure under normal conditions at the age of 8 wk, there would be a possibility that the heminephrectomy induces high blood pressure, especially in the SIRP␣-mutant mice. However, the heminephrectomy itself did not increase systolic pressure in both groups of mice (data not shown). In addition, systolic blood pressure was not increased until 6 wk after the adriamycin injection, when slightly increased systolic blood pressure was observed in the SIRP␣-mutant mice, possibly due to renal injury (data not shown). Therefore, blood pressure would not be a major factor to induce albuminuria and podocyte injury in the SIRP␣-mutant mice.
Adriamycin is well known to elicit podocyte injury resulting in heavy proteinuria and progressive renal failure in rats (12, 20) . However, in the case of mice, the susceptibility to adriamycin nephropathy is dependent on the strain (13, 30, 34) . BALB/c mice exhibit overt proteinuria and progression to significant glomerulosclerosis within 14 days of adriamycin injection, whereas C57BL/6 mice are known to be resistant to the deleterious effects of this drug on the kidneys (34) . The mice used in the current study were C57BL/6 background mice. The previous study showed that SIRP␣ plays crucial roles in integrin-mediated cytoskeletal reorganization and cell motility in other cell types (7, 18) . Considering our findings that foot processes were once well formed in the newborn kidney, but flattened during growth in the SIRP␣-mutant mice, glomerular filtration pressure acting after birth would affect the cytoskeletal integrity of podocytes in these mice. In addition, a much stronger stress on podocytes by adriamycin plus heminephrectomy may cause severe podocyte cytoskeletal dysregulation in the SIRP␣-mutant mice. Indeed, the podocyte-specific Myh9-deleted mice with C57BL/6 background develop proteinuria and glomerulosclerosis by adriamycin injection (9) . MYH9 interacts dynamically with F-actin to contract the cytoskeleton (24) . Although the precise mechanisms for the increased susceptibility of the SIRP␣-mutant mice to adriamycin-induced podocyte injury are not clear, our data suggest that the SIRP␣ signaling pathway functions protectively against podocyte injury.
SIRP␣-mutant mice do not manifest apparent developmental defects or growth retardation, indicating that SIRP␣ is not essential for embryonic or postnatal development (16) . However, SIRP␣-mutant mice have been reported to show several abnormalities, mainly in the hematological and immune systems (8, 21, 27, 32) . SIRP␣-mutant mice showed mild anemia and thrombocytopenia due to increased phagocytosis of red cells and platelets by macrophages (8, 32) . In addition, SIRP␣-mutant mice are resistant to experimental autoimmune encephalomyelitis or collagen-induced arthritis due to the inactivation of dendritic cells (21, 27) . Therefore, it is difficult to deny the possibility that aberrant SIRP␣ signaling outside the kidney may also influence the podocyte abnormalities. However, data from GLEPP1-deficient mice showed that these mice also manifest similar podocyte morphological abnormalities to those of the SIRP␣-mutant mice, suggesting that aberrant SIRP␣ signaling within the podocytes themselves is responsible for the podocyte abnormalities that we observed in the current study. A project to generate podocyte-specific SIRP␣-knockout mice is underway in our laboratory to elucidate the specific role of SIRP␣ in podocytes without the confounding effects of the influence of systemic SIRP␣ signaling. In summary, mice lacking the cytoplasmic domain of SIRP␣ showed morphological abnormalities of the podocytes, impaired renal function, and increased albuminuria compared with their wild-type counterparts. SIRP␣-mutant mice possessed irregular major processes and wider and flattened foot processes, similar to the podocyte abnormalities observed in GLEPP-1-deficient mice. In addition, SIRP␣-mutant mice exhibited massive albuminuria with glomerulosclerosis following adriamycin injection, whereas wild-type mice were resistant to the nephrotoxic effects of adriamycin. Our data demonstrated that the cytoplasmic domain of SIRP␣ is critically involved in podocyte structure and function under both physiological and pathological conditions. Further studies are warranted to identify the crucial molecular targets in the SIRP␣ signaling pathway in podocytes.
